Cargando…

Ginsenoside Rh2 Suppresses Metastasis and Growth of Colon Cancer via miR-491

Ginsenoside Rh2 is considered as a new direction for future cancer treatment because of its excellent anticancer effect. However, due to its low bioavailability, it cannot exert its significant anticancer effect when applied directly to the human body. Chitosan (CS), a nanomaterial, has been verifie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Wene, Guo, Qijing, Guo, Cuiping, Cui, Xianshu, Ma, Xuemei, Shen, Xianliang, Luo, Yushuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486518/ https://www.ncbi.nlm.nih.gov/pubmed/34603449 http://dx.doi.org/10.1155/2021/6815713

Ejemplares similares

Ginsenoside Rh2 suppresses colon cancer growth by targeting the miR-150-3p/SRCIN1/Wnt axis: Ginsenoside Rh2 inhibits colon cancer growth via miR-150-3p/SRCIN1/Wnt
por: Li, Shipeng, et al.
Publicado: (2023)

Tumor Suppressive Role of miR-342-5p and miR-491-5p in Human Osteosarcoma Cells
por: Veys, Clément, et al.
Publicado: (2022)

Low Expression of miR-491-3p Is Correlated with Lymph Node Metastasis in Gastric Cancer
por: Yu, Haiou, et al.
Publicado: (2022)

Downregulation of miR‐491‐5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4
por: Yu, Ting, et al.
Publicado: (2018)

miR-491-3p is Downregulated in Retinoblastoma and Inhibit Tumor Cells Growth and Metastasis by Targeting SNN
por: Hu, Yang, et al.
Publicado: (2020)

Retracted: Low Expression of miR-491-3p Is Correlated with Lymph Node Metastasis in Gastric Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Interaction between linc01615 and miR-491-5p regulates the survival and metastasis of colorectal cancer cells
por: Xiao, You, et al.
Publicado: (2020)

Integrated pan-cancer analysis and experimental verification of the roles of tropomyosin 4 in gastric cancer
por: Guo, Qijing, et al.
Publicado: (2023)

Downregulation of miR-491-5p promotes neovascularization after traumatic brain injury
por: Tang, Wei, et al.
Publicado: (2021)

Differentially expressed mRNAs and their upstream miR-491-5p in patients with coronary atherosclerosis as well as the function of miR-491-5p in vascular smooth muscle cells
por: Ding, Hui, et al.
Publicado: (2022)

The interaction of serum albumin with ginsenoside Rh2 resulted in the downregulation of ginsenoside Rh2 cytotoxicity
por: Lin, Yingjia, et al.
Publicado: (2017)

Ginsenoside Rh4 Suppressed Metastasis of Lung Adenocarcinoma via Inhibiting JAK2/STAT3 Signaling
por: Zhang, Yan, et al.
Publicado: (2022)

Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma
por: Li, Xia, et al.
Publicado: (2014)

miR-491 regulates glioma cells proliferation by targeting TRIM28 in vitro
por: Qi, Zengxin, et al.
Publicado: (2016)

miR-491-5p inhibits osteosarcoma cell proliferation by targeting PKM2
por: Chen, Ting, et al.
Publicado: (2018)

TAp63 suppress metastasis via miR-133b in colon cancer cells
por: Lin, C W, et al.
Publicado: (2014)

miR-17–92 cluster is connected with disease progression and oxaliplatin/capecitabine chemotherapy efficacy in advanced gastric cancer patients: A preliminary study
por: Fan, Baohua, et al.
Publicado: (2018)

MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1
por: Zhang, Yajie, et al.
Publicado: (2016)

lncRNA H19 promotes glioblastoma multiforme development by activating autophagy by sponging miR-491-5p
por: Wang, Guo, et al.
Publicado: (2022)

Ginsenoside Rh7 Suppresses Proliferation, Migration and Invasion of NSCLC Cells Through Targeting ILF3-AS1 Mediated miR-212/SMAD1 Axis
por: Chen, Xiangbo, et al.
Publicado: (2021)

Ginsenoside Rh2 inhibits thyroid cancer cell migration and proliferation via activation of miR-524-5p
por: Jiang, Shan, et al.
Publicado: (2020)

miR-491-5p inhibits the proliferation and migration of A549 cells by FOXP4
por: Wu, Fuyong, et al.
Publicado: (2021)

Reversal effect of ginsenoside Rh2 on oxaliplatin-resistant colon cancer cells and its mechanism
por: Ma, Jun, et al.
Publicado: (2019)

Structure Modification of Ginsenoside Rh(2) and Cytostatic Activity on Cancer Cells
por: Liang, Junyu, et al.
Publicado: (2023)

Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulation
por: Wu, Milu, et al.
Publicado: (2018)

Ginsenoside Rh4 Suppresses Metastasis of Esophageal Cancer and Expression of c-Myc via Targeting the Wnt/β-Catenin Signaling Pathway
por: Chen, Jun, et al.
Publicado: (2022)

MIR-491: CDKN2A tumor suppressor co-pilot
por: Moore, Lynette M., et al.
Publicado: (2015)

miR-491-5p functions as a tumor suppressor by targeting IGF2 in colorectal cancer
por: Lu, Lei, et al.
Publicado: (2019)

Network-Based Integration of Multi-Omics Data Identifies the Determinants of miR-491-5p Effects
por: Meryet-Figuiere, Matthieu, et al.
Publicado: (2021)

Ginsenoside Rh4 Suppresses Metastasis of Gastric Cancer via SIX1-Dependent TGF-β/Smad2/3 Signaling Pathway
por: Jiang, Hongbo, et al.
Publicado: (2022)

Response to comment on ‘TAp63 suppress metastasis via miR-133b in colon cancer cells'
por: Lin, C W, et al.
Publicado: (2014)

Induction of apoptosis in prostate cancer by ginsenoside Rh2
por: Tong-Lin Wu, Tony, et al.
Publicado: (2018)

MiR-23a targets RUNX2 and suppresses ginsenoside Rg1-induced angiogenesis in endothelial cells
por: Wu, Xiao-Dong, et al.
Publicado: (2017)

Reduced Circulating Levels of miR-491-5p and miR-485-3p Are Associated with the Occurrence of Vertebral Fractures in Postmenopausal Women with Osteoporosis
por: Xu, Jixi, et al.
Publicado: (2022)

Urinary Levels of miR-491-5p and miR-592 as Potential Diagnostic Biomarkers in Female Aging Patients with OAB: A Pilot Study
por: Cammisotto, Philippe G., et al.
Publicado: (2022)

Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2
por: Xie, Zheng-Yuan, et al.
Publicado: (2018)

circ-0000212 promotes cell proliferation of colorectal cancer by sponging miR-491 and modulating FOXP4 expression
por: Wu, Hongyu, et al.
Publicado: (2021)

Biotransformation of Ginsenoside Rf to Rh(1) by Recombinant β-Glucosidase
por: Ruan, Chang-Chun, et al.
Publicado: (2009)

MiR-491-5p, as a Tumor Suppressor, Prevents Migration and Invasion of Breast Cancer by Targeting ZNF-703 to Regulate AKT/mTOR Pathway
por: Guo, Jingyun, et al.
Publicado: (2021)

Mechanism-Based Pharmacokinetic Model for the Deglycosylation Kinetics of 20(S)-Ginsenosides Rh2
por: Ren, Hong-can, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_draj18cndgug2bti71s6r8i40o